LAVAL, Quebec, March 21, 2016 / PRNewswire / — Valeant Pharmaceuticals International, Inc. (NYSE: VRX)(TSX: VRX)
today announced that it has initiated a search for a new chief
executive officer, appointed William A. Ackman to its board
of directors, and provided an update on certain
accounting and financial reporting matters.
Attorneys: Staff Legal Counsel (Financial Services and Hospitality) Chief
Executive Officer: Banking, Technology, Credit Union, Non-Profit Organization Chief Financial Officer
Accounting & Finance: Controller, CPA, Finance Director, Director
of Accounting, Financial Analyst, Business Analyst Financial Services: Bank Manager, Director
of Security, Senior Director
of Portfolio Services, Trader, Hedge Fund Controller, Foreign Exchange (FX) Director Healthcare: Registered Nurse, Physical Therapist, LPN, Radiologist, Radiology Technician, Phlebotomist Healthcare Administration: Program Developer, VP Revenue Cycle Management, HER / EMR Sales, Healthcare Insurance Administration, Insurance Claims Director Human Resources: VP
of HR, HR Director, HR Generalist, HR Manager Information Technology: IT Services Director, VP
of IT Security, Web Developer, IT Infrastructure Engineer, Network Support Specialist, Network Engineer, IT Project Manager, Desktop Infrastructure Director Manufacturing: Supply Chain Director, Manufacturing Engineer, Subcontract Administrator Non-Profit: Development Director, Manager
of Donor Relations Physical Security: Site Director, Corporate Security Director, Loss Prevention Manager Professional Services: Recruiting, Project Manager (PMP), Site Surveyor, Construction Project Manager Retail: Senior Vice President, Multi-Site Managers / Directors, Big - Box Store Manager, Assistant Store Manager Sales: National Sales Manager, Field Sales Director,
Account Executive (IT, UC, others), Medical Equipment Sales, Pharmaceutical Sales Teaching: Elementary School Teacher, Middle School Teacher, LibrarianLet's get started
today.